-
FEATURE: Biodiversity credits: profiting from nature’s last frontier
15 November 2023
Why biodiversity credits probably won’t remedy the sixth mass extinction.
News / Sustainability / Health / Education
-
Big Pharma Days Numbered
05 July 2017
Making way for a parallel medical system based on the principles of natural health
-
Rob Verkerk PhD with Charles Kovess on the Mind Medicine Show, TNT Radio
06 September 2023
Dive into the wide ranging, natural health-related discussion between Rob Verkerk PhD and Charles Kovess on the TNT Radio Mind Medicine Show last weekend
-
ANH News Beat (week 26/2023)
28 June 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
How do the current EU rules & regulations affect your practice?
18 July 2023
All practitioners, whether medically qualified or qualified in some other way, are affected one way or another by EU laws if they live, or more importantly practice, anywhere within the European Union (EU).
-
ANH News Beat (week 24/2023)
15 June 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
Why misinformation bans are misinformed and dangerous
24 May 2023
In the light of this week’s Nobel Prize Summit, we explain why censorship is so dangerous, and why we need, in contrast, to broaden the scope of available information and foster dialogue and critical thinking
News / ANH Covid Zone / Health / Campaigns
-
ANH News Beat (week 18/2023)
05 May 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
FEATURE: How the Nobel Prize Summit sold out on real science
12 June 2023
Despite noble ambitions, the Washington DC Nobel summit looked more like a breeding ground for AI-infused dogma and big corporate backed pseudoscience
News / ANH Covid Zone / Health / Campaigns
-
Regulatory limbo: the case of NAC
13 April 2023
The more effective a natural product, the greater the risk if it sits in an uncertain, regulatory ‘no man’s land’